Bionx keeps its lead in the knee repair market with its resorbable Meniscus Arrow
This article was originally published in Clinica
Executive Summary
There could soon be a new player in the $100 million meniscal repair market in the US. But Bionx Implants, the company which claims to have created the sector when it launched its flagship product - the Meniscus Arrow - little more than a year ago, is confident of retaining its leadership position.